INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,629 | -39.1% | 4,081 | -18.3% | 0.00% | – |
| Q2 2023 | $45,346 | +45.7% | 4,994 | +3.7% | 0.00% | – |
| Q1 2023 | $31,119 | +64.3% | 4,817 | +61.2% | 0.00% | – |
| Q4 2022 | $18,944 | -97.6% | 2,988 | -97.7% | 0.00% | – |
| Q3 2022 | $800,000 | -56.5% | 129,000 | -38.1% | 0.00% | – |
| Q2 2022 | $1,841,000 | -27.2% | 208,282 | -30.7% | 0.00% | – |
| Q1 2022 | $2,530,000 | -34.5% | 300,481 | -20.6% | 0.00% | – |
| Q4 2021 | $3,861,000 | +707.7% | 378,487 | +1436.6% | 0.00% | – |
| Q3 2021 | $478,000 | +135.5% | 24,631 | +113.4% | 0.00% | – |
| Q2 2021 | $203,000 | +448.6% | 11,543 | +273.2% | 0.00% | – |
| Q1 2021 | $37,000 | +37.0% | 3,093 | +97.4% | 0.00% | – |
| Q4 2020 | $27,000 | +170.0% | 1,567 | +56.7% | 0.00% | – |
| Q3 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |